 rate compared
with the other procedures, which had all had similar
reintervention rates. The cost of EVLA vs UGFS was
Â£16,966 ($23,700) per quality-adjusted life-year, supporting EVLA as the most cost-effective procedure. RFA was
a close second, and MOCA, UGFS, CAC, conservative
care, and high ligation and stripping were not costeffective at the current prices in